INMUNE BIO INC. - COMM
5.0500
29-11月-24 13:45:00
15 分の遅延
株式
+0.1600
+3.27%
本日の幅
4.8600 - 5.0500
ISIN
N/A
ソース
NASDAQ
-
13 11 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update
31 10 2024 16:05:51 提供 Nasdaq GlobeNewswire
-
INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
28 10 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination
24 10 2024 15:03:00 提供 Nasdaq GlobeNewswire
-
24 10 2024 09:30:00 提供 Nasdaq GlobeNewswire
-
INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit
11 10 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease
30 9 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
INKmune™ Demonstrates Excellent Safety and Increased NK-Cell Activity in First Dosing Cohort
26 9 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
17 9 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
INmune Bio Announces $13.0 Million Registered Direct Offering
13 9 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference
03 9 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update
01 8 2024 16:05:39 提供 Nasdaq GlobeNewswire
-
29 7 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
25 7 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
23 7 2024 08:45:00 提供 Nasdaq GlobeNewswire
-
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
27 6 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
INmune Bio Inc. to Join Russell 3000® Index
30 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
09 5 2024 16:05:36 提供 Nasdaq GlobeNewswire
-
07 5 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
30 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >